Takeda Pharmaceutical Co., Wyeth deal

WYE increased to 80% from 70% its stake in the companies' Wyeth K.K. joint venture, which was formed in 2003 (see BioCentury, May 26, 2003). The partners co-promote Enbrel etanercept in Japan, where...